FDA Summary Review AMYLYX PHARMS NDA 216660

Summary Review

NDA 216660

AMYLYX PHARMS

Application #216660

Documents

Summary Review2022-09-29

Application Sponsors

NDA 216660AMYLYX PHARMS
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.